Societe Des Produits Nestle S.a.

Nestec S.a.

Timothy James Wooster

Clara Lucia Garcia-Rodenas

Sagar Thakkar

Ebenezer Satyaraj

Laurence Donato-Capel

Beat Gerber

Anwesha Sarkar

Simone Acquistapace

Eddy Gombas

Bruno Chavez Montes

Dominique Jaccard

Hugues Lefait

Kim-Anne Le

Thierry Fellay

Kornél Nagy

Philippe René Pollien

Compositions and methods reduce symptoms of human allergy to cats. The effectiveness of a molecule which specifically binds to Feline domesticus allergen number 1 (Fel D1) is enhanced by prolonging the time the immunoglobulin stays within the mouth of a cat to whom the anti-Fel D1 molecule is administered in a pet food. The compositions and methods use a powder that is a dried hydrogel encapsulating the anti-Fel D1 molecule, and the hydrogel is based on gelatin, collagen peptides, or gelatin and collagen peptides; and carrageenan. The methods of making the powder provide a high encapsulation efficacy, sustained release of the anti-Fel D1 molecule in the cat's mouth, and oral adhesion of the anti-Fel D1 molecule in the cat's mouth.

Compositions and methods for reducing at least one symptom of human allergy to cats

Compositions and methods reduce symptoms of human allergy to cats. The effectiveness of a molecule which specifically binds toallergen number 1 (Fel D1) is enhanced by prolonging the time the immunoglobulin stays within the mouth of a cat to whom the anti-Fel D1 molecule is administered in a pet food. The compositions and methods use a powder that is a dried hydrogel encapsulating the anti-Fel D1 molecule, and the hydrogel is based on gelatin, collagen peptides, or gelatin and collagen peptides; and carrageenan. The methods of making the powder provide a high encapsulation efficacy, sustained release of the anti-Fel D1 molecule in the cat's mouth, and oral adhesion of the anti-Fel D1 molecule in the cat's mouth.

A delivery vehicle with a core surrounded by a digestible polymer shell having a melting and/or softening point above the body temperature of an animal or human, and where the core has a lipid and/or lipophilic active ingredient dispersed in a continuous polymer matrix. The delivery vehicle can be used to release lipid and/or lipophilic active ingredients, such as pharmaceuticals, nutraceuticals, supplements, traditional/herbal medicine, or combinations thereof, after a predetermined lag time following ingestion.

Delivery system comprising a core and a digestible polymer shell

A delivery vehicle comprising a core () surrounded by a digestible polymer shell () having a melting and/or softening point above the body temperature of an animal or human, wherein said core comprises a lipid and/or lipophilic active ingredient () dispersed in a continuous polymer matrix (). The delivery vehicle can be used to release lipid and/or lipophilic active ingredients, such as pharmaceuticals, nutraceuticals, supplements, traditional/herbal medicine, or combinations thereof, after a predetermined lag time following ingestion.

Growing community of inventors

Epalinges, Switzerland

Timothy James Wooster